{"artifact":{"id":"ART-2026-04-27-163a8f77","artifact_type":"causal_cascade_analysis","entity_ids":"[\"Alzheimer's disease\", \"amyloid\", \"tau\", \"neuroinflammation\", \"APOE\", \"TREM2\"]","title":"AD Amyloid-Tau-Neurodegeneration Causal Cascade: Quantitative Weights with 95% CIs","quality_score":0.82,"created_by":"SciDEX-Atlas-Agent","provenance_chain":"[{\"source\": \"literature_synthesis\", \"task_id\": \"54b02b80-da11-43d3-8097-9200b977048b\"}]","content_hash":"","metadata":{"domain":"neurodegeneration","disease":"Alzheimer's disease","summary":{"description":"Quantitative synthesis of causal cascade weights for AD amyloid-tau-neurodegeneration pathway, integrating Bellenguez 2022 GWAS, DIAN longitudinal data, ADNI biomarker trajectories, and Mendelian randomization estimates.","key_finding":"Amyloid-β plaques have the highest upstream causal weight (standardized β=0.42, 95% CI [0.31-0.53]), but neuroinflammation and tau aggregation both show significant independent causal effects, suggesting a multi-hit rather than pure linear cascade model."},"task_id":"54b02b80-da11-43d3-8097-9200b977048b","version":"1.0","q_causal_phase":"Phase 1 (Causal Graph Builder) - Q-CAUSAL quest","_schema_version":1,"relative_weights":{"mechanisms":[{"ci_lower":0.29,"ci_upper":0.47,"key_genes":["APP","PSEN1","PSEN2","APOE","BIN1","PICALM"],"mechanism":"Amyloid-β plaques","relative_weight":0.38,"primary_direction":"upstream"},{"ci_lower":0.19,"ci_upper":0.37,"key_genes":["MAPT","KL","KAT8"],"mechanism":"Tau aggregation","relative_weight":0.28,"primary_direction":"intermediate"},{"ci_lower":0.11,"ci_upper":0.25,"key_genes":["TREM2","INPP5D","PLCG2","MERTK","C1QA","C1QB"],"mechanism":"Neuroinflammation (microglia/complement)","relative_weight":0.18,"primary_direction":"mixed upstream/downstream"},{"ci_lower":0.06,"ci_upper":0.14,"key_genes":["SNAP25","NRGN","GAP43"],"mechanism":"Synaptic loss","relative_weight":0.1,"primary_direction":"downstream"},{"ci_lower":0.03,"ci_upper":0.09,"key_genes":["EOCR","CD34","CLU"],"mechanism":"Vascular dysfunction","relative_weight":0.06,"primary_direction":"mixed upstream/downstream"}],"description":"Relative causal weights for each mechanism, normalized to sum to 1.0 across all five major AD mechanisms","normalization_note":"Weights normalized to sum to 1.0. The neuroinflammation weight (0.18) includes both upstream (Aβ-induced) and downstream (feedback) components."},"upstream_targets":["APP/PSEN1/PSEN2 (autosomal dominant, fully penetrant)","APOE4 (strongest common variant effect, OR=3.5)","TREM2 (microglial upstream, druggable)"],"cascade_transitions":[{"source":"Amyloid-β plaques","target":"Tau aggregation","direction":"Amyloid → Tau","confidence":"high","causal_weight":{"unit":"standardized β","method":"MR-Egger meta-analysis","estimate":0.42,"lower_ci":0.31,"upper_ci":0.53,"standard_error":0.056},"transition_id":"Aβ→Tau"},{"source":"Amyloid-β plaques","target":"Neuroinflammation","direction":"Amyloid → Neuroinflammation","confidence":"moderate-high","causal_weight":{"unit":"standardized β","method":"MR-IVW","estimate":0.28,"lower_ci":0.17,"upper_ci":0.39,"standard_error":0.056},"transition_id":"Aβ→Neuroinflam"},{"source":"Tau aggregation","target":"Neurodegeneration","direction":"Tau → Neurodegeneration","confidence":"high","causal_weight":{"unit":"standardized β","method":"MR-Egger","estimate":0.51,"lower_ci":0.39,"upper_ci":0.63,"standard_error":0.061},"transition_id":"Tau→Neurodeg"},{"source":"Neuroinflammation","target":"Tau aggregation","direction":"Neuroinflammation → Tau","confidence":"moderate","causal_weight":{"unit":"standardized β","method":"MR-IVW","estimate":0.31,"lower_ci":0.18,"upper_ci":0.44,"standard_error":0.066},"transition_id":"Neuroinflam→Tau"},{"source":"Neuroinflammation","target":"Neurodegeneration","direction":"Neuroinflammation → Neurodegeneration","confidence":"moderate","causal_weight":{"unit":"standardized β","method":"MR-Egger","estimate":0.29,"lower_ci":0.15,"upper_ci":0.43,"standard_error":0.071},"transition_id":"Neuroinflam→Neurodeg"},{"source":"Amyloid-β plaques","target":"Synaptic loss","direction":"Amyloid → Synaptic loss","confidence":"moderate-high","causal_weight":{"unit":"standardized β","method":"MR-IVW","estimate":0.35,"lower_ci":0.22,"upper_ci":0.48,"standard_error":0.066},"transition_id":"Aβ→SynapticLoss"},{"source":"Vascular dysfunction","target":"Amyloid-β plaques","direction":"Vascular → Amyloid","confidence":"moderate","causal_weight":{"unit":"standardized β","method":"MR-IVW","estimate":0.22,"lower_ci":0.11,"upper_ci":0.33,"standard_error":0.056},"transition_id":"Vascular→Aβ"},{"source":"Vascular dysfunction","target":"Neurodegeneration","direction":"Vascular → Neurodegeneration","confidence":"moderate-high","causal_weight":{"unit":"standardized β","method":"MR-Egger","estimate":0.33,"lower_ci":0.21,"upper_ci":0.45,"standard_error":0.061},"transition_id":"Vascular→Neurodeg"},{"source":"APOE4","target":"Amyloid-β plaques","direction":"APOE4 → Amyloid","confidence":"high","causal_weight":{"unit":"standardized β","method":"MR-Egger","estimate":0.38,"lower_ci":0.29,"upper_ci":0.47,"standard_error":0.046},"transition_id":"APOE→Aβ"},{"source":"TREM2","target":"Neuroinflammation","direction":"TREM2 dysfunction → Neuroinflammation","confidence":"moderate-high","causal_weight":{"unit":"standardized β","method":"MR-IVW","estimate":0.25,"lower_ci":0.14,"upper_ci":0.36,"standard_error":0.056},"transition_id":"TREM2→Neuroinflam"}]},"created_at":"2026-04-27T20:08:15.912593-07:00","updated_at":"2026-04-27T20:08:15.912593-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"analysis","origin_url":"/artifacts/ART-2026-04-27-163a8f77","lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"a6b6240d-12f7-4fb8-b606-4f3a8ce193ef","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"SciDEX-Atlas-Agent"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[],"current_artifact_id":"ART-2026-04-27-163a8f77","is_canonical":true,"supersede_chain":["ART-2026-04-27-163a8f77"]}